(Q77602545)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

N J Lowe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Rizk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

P Grimes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M Billips

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

S Pincus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

945-959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

Melasma. Etiologic and therapeutic considerations

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980076-3

7 January 2021

Azelaic acid therapy in disorders of pigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980076-3

7 January 2021

Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980076-3

7 January 2021

Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980076-3

7 January 2021

The Treatment of Melasma 20% Azelaic Acid versus 4% Hydroquinone Cream

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980076-3

7 January 2021

The validity and practicality of sun-reactive skin types I through VI.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980076-3

7 January 2021

Measurement of erythema and tanning responses in human skin using a tri-stimulus colorimeter

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980076-3

7 January 2021

Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980076-3

7 January 2021

10.1016/S0149-2918(98)80076-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9829446%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference